Describe the impact of hypersomnolence due to IH and narcolepsy on patient QoL and ongoing challenges associated with its recognition, diagnosis, and management, particularly among patients with comorbid illness Evaluate the safety, efficacy, and MOA data associated with current and emerging pharmacological treatment options for excessive sleepiness in IH and narcolepsy Implement strategies to improve collaboration and communication among clinicians who care for patients with IH or narcolepsy to ensure optimal treatment selection and patient care
- Provider:HMP Education
- Activity Link: https://hmpeducation.com/program/24-elevate-101-5
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours
Psychology: 1.0 hours
Social Work: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Jazz Pharmaceuticals, Inc. - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest